[1]
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017 Sep 16:390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2. Epub
[PubMed PMID: 28919117]
Level 1 (high-level) evidence
[2]
Jain S, Malinowski M, Chopra P, Varshney V, Deer TR. Intrathecal drug delivery for pain management: recent advances and future developments. Expert opinion on drug delivery. 2019 Aug:16(8):815-822. doi: 10.1080/17425247.2019.1642870. Epub 2019 Jul 19
[PubMed PMID: 31305165]
Level 3 (low-level) evidence
[3]
. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia : an international journal of headache. 2018 Jan:38(1):1-211. doi: 10.1177/0333102417738202. Epub
[PubMed PMID: 29368949]
[5]
Gunesli A, Tufan K. Significance of the Cerebellopontine Cistern Cross-Sectional Area and Trigeminal Nerve Anatomy in Trigeminal Neuralgia: An Anatomical Study Using Magnetic Resonance Imaging. Turkish neurosurgery. 2020:30(2):271-276. doi: 10.5137/1019-5149.JTN.27735-19.2. Epub
[PubMed PMID: 32091126]
Level 2 (mid-level) evidence
[6]
Williams MH, Broadley SA. SUNCT and SUNA: clinical features and medical treatment. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2008 May:15(5):526-34. doi: 10.1016/j.jocn.2006.09.006. Epub 2008 Mar 5
[PubMed PMID: 18325769]
[7]
Favoni V, Grimaldi D, Pierangeli G, Cortelli P, Cevoli S. SUNCT/SUNA and neurovascular compression: new cases and critical literature review. Cephalalgia : an international journal of headache. 2013 Dec:33(16):1337-48. doi: 10.1177/0333102413494273. Epub 2013 Jun 25
[PubMed PMID: 23800827]
Level 3 (low-level) evidence
[8]
Martins IP, Viana P, Lobo PP. Familial SUNCT in mother and son. Cephalalgia : an international journal of headache. 2016 Sep:36(10):993-7. doi: 10.1177/0333102415616879. Epub 2015 Nov 8
[PubMed PMID: 26553730]
[9]
Arca KN, Halker Singh RB. SUNCT and SUNA: an Update and Review. Current pain and headache reports. 2018 Jun 21:22(8):56. doi: 10.1007/s11916-018-0707-3. Epub 2018 Jun 21
[PubMed PMID: 29931416]
[10]
Ossipov MH, Raffa RB, Pergolizzi JV. Galcanezumab: a humanized monoclonal antibody for the prevention of migraine and cluster headache. Drugs of today (Barcelona, Spain : 1998). 2020 Jan:56(1):5-19. doi: 10.1358/dot.2020.56.1.3069863. Epub
[PubMed PMID: 32055802]
[11]
Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. The Lancet. Neurology. 2002 Aug:1(4):251-7
[PubMed PMID: 12849458]
[12]
Jain S, Yuan H, Spare N, Silberstein SD. Erenumab in the treatment of migraine. Pain management. 2018 Nov 1:8(6):415-426. doi: 10.2217/pmt-2018-0037. Epub 2018 Sep 21
[PubMed PMID: 30235976]
[13]
Miller S,Akram H,Lagrata S,Hariz M,Zrinzo L,Matharu M, Ventral tegmental area deep brain stimulation in refractory short-lasting unilateral neuralgiform headache attacks. Brain : a journal of neurology. 2016 Oct;
[PubMed PMID: 27524793]
[14]
Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA. Brain : a journal of neurology. 2006 Oct:129(Pt 10):2746-60
[PubMed PMID: 16905753]
[16]
Weng HY, Cohen AS, Schankin C, Goadsby PJ. Phenotypic and treatment outcome data on SUNCT and SUNA, including a randomised placebo-controlled trial. Cephalalgia : an international journal of headache. 2018 Aug:38(9):1554-1563. doi: 10.1177/0333102417739304. Epub 2017 Nov 2
[PubMed PMID: 29096522]
Level 1 (high-level) evidence
[17]
Rossi P, Cesarino F, Faroni J, Malpezzi MG, Sandrini G, Nappi G. SUNCT syndrome successfully treated with topiramate: case reports. Cephalalgia : an international journal of headache. 2003 Dec:23(10):998-1000
[PubMed PMID: 14984234]
Level 3 (low-level) evidence
[18]
Matharu MS, Cohen AS, Boes CJ, Goadsby PJ. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review. Current pain and headache reports. 2003 Aug:7(4):308-18
[PubMed PMID: 12828881]
[19]
Pareja JA, Kruszewski P, Sjaastad O. SUNCT syndrome: trials of drugs and anesthetic blockades. Headache. 1995 Mar:35(3):138-42
[PubMed PMID: 7721573]
[20]
Deer TR, Jain S, Hunter C, Chakravarthy K. Neurostimulation for Intractable Chronic Pain. Brain sciences. 2019 Jan 24:9(2):. doi: 10.3390/brainsci9020023. Epub 2019 Jan 24
[PubMed PMID: 30682776]
[21]
Deer TR, Grider JS, Lamer TJ, Pope JE, Falowski S, Hunter CW, Provenzano DA, Slavin KV, Russo M, Carayannopoulos A, Shah JM, Harned ME, Hagedorn JM, Bolash RB, Arle JE, Kapural L, Amirdelfan K, Jain S, Liem L, Carlson JD, Malinowski MN, Bendel M, Yang A, Aiyer R, Valimahomed A, Antony A, Craig J, Fishman MA, Al-Kaisy AA, Christelis N, Rosenquist RW, Levy RM, Mekhail N. A Systematic Literature Review of Spine Neurostimulation Therapies for the Treatment of Pain. Pain medicine (Malden, Mass.). 2020 Nov 7:21(7):1421-1432. doi: 10.1093/pm/pnz353. Epub
[PubMed PMID: 32034422]
Level 1 (high-level) evidence
[22]
Jain S, Fishman MA, Wu C. Significant cephalad lead migration with use of externally powered spinal cord stimulator. BMJ case reports. 2018 Sep 21:2018():. pii: bcr-2018-225813. doi: 10.1136/bcr-2018-225813. Epub 2018 Sep 21
[PubMed PMID: 30244224]
Level 3 (low-level) evidence
[23]
Cohen AS. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing. Cephalalgia : an international journal of headache. 2007 Jul:27(7):824-32
[PubMed PMID: 17598764]